Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024

REDWOOD CITY, Calif., Jan. 29, 2024 /PRNewswire/ — Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the company will release its financial results for the fourth…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks